TomoTherapy, a maker of the Hi-Art treatment system for advanced radiation therapy, has entered into an agreement to acquire privately held linear accelerator manufacturer Chengdu Twin Peak Accelerator Technology, based in Chengdu, China.
The linear accelerators designed, developed and manufactured by Twin Peak will be used to supplement TomoTherapy’s existing supply source, according to the Madison, Wis.-based TomoTherapy.
The financial terms of the transaction were not disclosed. TomoTherapy said it anticipates that the transaction will close in approximately 90 days.
“The acquisition of Twin Peak represents a substantial advance in our ability to control the quality and features of our products. This is also a piece of our longer-term strategy of reducing the cost of the Hi-Art treatment system to improve margins,” according to Fred Robertson, CEO of TomoTherapy.